A new study reveals that almost half of patients with metastatic melanoma treated with these drugs were cancer-free 10 years ...

Being told you have cancer is like a dark cloud over your life. It’s tough, no matter the type of cancer. Every day feels ...

Aura Biosciences' strong data, focus on an unmet medical need, and solid execution make it a compelling biotech investment.

Hello Health Rounds Readers! Today we highlight research findings reported at ESMO 2024, the annual meeting of the European ...

Strategies that use the body’s natural defence system to fight cancer, an approach known as immunotherapy, have already shown ...

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain ...

Achilles to discontinue development of TIL-based cNeT therapy- -Cash position of $95.1 million as of June 30, 2024- -BofA Securities engaged to provide strategic financial advice- LONDON ...

remain a leading cause of cancer deaths and a major challenge to women's health worldwide. Immunotherapy has greatly improved ...

Investorideas.com, a go-to investing platform, releases the second of a two-part series looking at news and developments ...

The Chinese-Canadian scientist, whose discoveries made immunotherapy possible, predicts that the relationship between the ...

Researchers have identified five independent factors that predict cancer patients' response to checkpoint inhibitors (CPIs). The study validates these factors in more than 1,400 patients and diverse ...

The RESILIENCE clinical trial has been designed to explore the effectiveness and safety of remote ischemic conditioning (RIC) ...